ABCDEFGHIJKLMNOPQRSTUVWXYZ
1
Cost-effectiveness estimatesCEDOVIP
2
3
4
Summary cost-per DALY calculation
5
IndicatorsPercentageNumberSources
6
Total population reached by CEDOVIP100% 168,031 Monitoring data
7
Number of females reached62.0% 63,852 Monitoring data
8
Expected number of cases among the females56.0% 58,340 Literature
9
Number of cases averted due to the intervention52.0% 30,337 Literature
10
Per case disability burden 0.0720Estimated from GBD study
11
Number of DALYs averted 2,186 Estimated
12
Total costs of the intervention for 2024 in US$ 692,203 Monitoring data
13
Cost per DALY averted US$316.7Estimated
14
GDP per capita of Uganda in US$ in 2024 3,275.8 World Bank
15
16
17
18
19
Estimates
20
Population informationNumberNotes
21
Total population48,656,601In 2023 WB
22
Male 24,122,612ibid
23
Female24,533,989ibid
24
ItemPercentageNumber Notes
25
Total population reached 100.0% 168,031
26
Male 38.0% 63,852
27
Female62.0% 104,179
28
Expected number of cases56.0% 58,340
IPV prevalence in Uganda in 2020. Source: Uganda Bureau of Statistics (UBOS). 2021. Uganda Violence Against Women and Girls Survey 2020. Kampala, Uganda.
29
Effect of CEDOVIP52.0% 30,337
Lower IPV among women in the past year. Source: https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-014-0122-5
30
DALYs averted0.072 per case 2,186
Estimated using DALYs and prevalence
33
34
35
36
37
Other notes
38
There is no endline indicator available. Therefore we have use GBD study information.
39
Main focus on VAW.
40
Although the intervention is targeted for women it may also have effect on reducing violence against men (VAM). The prevalence of VAM is higher compared to VAW in Uganda. However, this may be due to men being more likely to report violence incidence than females.
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102